Darentang schedules half-year performance briefing and investor day

Tianjin Darentang Pharmaceutical Group Corp. is scheduled to host its 2025 half-year performance briefing and participate in the Tianjin jurisdiction's listed companies' online collective investor reception day. The event will take place on Thursday, September 11, 2025, from 15:00 to 17:00, accessible via the "All-Scene Roadshow" website (http://rs.p5w.net).

Key company representatives attending include chairperson Wang Lei, cfo Ma Jian, an independent director representative, and board secretary Jiao Yan. Investors have the opportunity to submit questions in advance via email to drt600329@163.com by 17:00 on Monday, September 8, 2025. The company commits to addressing commonly raised questions during the session.

This briefing follows the release of the company's 2025 half-year report on August 15, 2025, published on the Shanghai Stock Exchange website (www.sse.com.cn). For further inquiries, investors can contact Wang Jian or Jiang Ling at 022-27020892 or drt600329@163.com.